ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $957,000 | -13.7% | 29,415 | -2.6% | 0.00% | -100.0% |
Q2 2021 | $1,109,000 | -21.7% | 30,200 | -28.3% | 0.00% | 0.0% |
Q1 2021 | $1,417,000 | -39.3% | 42,097 | -32.9% | 0.00% | -50.0% |
Q4 2020 | $2,336,000 | +10518.2% | 62,757 | +10104.4% | 0.00% | – |
Q3 2020 | $22,000 | -97.7% | 615 | -98.4% | 0.00% | -100.0% |
Q2 2020 | $948,000 | +73.0% | 37,434 | +7.0% | 0.00% | 0.0% |
Q1 2020 | $548,000 | -36.6% | 35,000 | +3.0% | 0.00% | 0.0% |
Q4 2019 | $864,000 | +3500.0% | 33,995 | +2704.9% | 0.00% | – |
Q3 2019 | $24,000 | -36.8% | 1,212 | +3.1% | 0.00% | – |
Q2 2019 | $38,000 | -74.3% | 1,175 | -74.4% | 0.00% | – |
Q1 2019 | $148,000 | +35.8% | 4,588 | +2.9% | 0.00% | – |
Q4 2018 | $109,000 | -24.3% | 4,457 | +1.5% | 0.00% | – |
Q3 2018 | $144,000 | -7.7% | 4,393 | -0.0% | 0.00% | – |
Q2 2018 | $156,000 | +9.9% | 4,395 | +1.5% | 0.00% | – |
Q1 2018 | $142,000 | – | 4,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |